BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil

被引:6
作者
Mazzonetto, Patricia [1 ]
Milanezi, Fernanda [1 ]
D'Andrea, Mariana [1 ]
Martins, Silvia [1 ]
Monfredini, Priscilla M. [1 ]
Silva, Juliana dos Santos [1 ]
Perrone, Eduardo [1 ]
Villela, Darine [1 ]
Schnabel, Beatriz [1 ]
Nakano, Viviane [1 ]
Palmero, Edenir Inez [1 ]
Braggio, Esteban [1 ]
Cavalcanti, Thereza L. [1 ]
Guida, Gustavo [1 ]
Migliavacca, Michele P. [1 ]
Scapulatempo-Neto, Cristovam [1 ]
Zalcberg, Ilana [1 ]
机构
[1] Diagnost Amer SA, DASA, Av Divino Salvador, 876 3Rd Floor, BR-04078013 Sao Paulo, SP, Brazil
关键词
BRCA1; BRCA2; Germline mutation; Genetic testing; Hereditary breast and ovarian cancer; Brazilian population; HEREDITARY BREAST; OVARIAN-CANCER; WOMEN; VARIANTS;
D O I
10.1007/s10549-023-06892-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We determined the frequency and mutational spectrum of BRCA1 and BRCA2 in a series of patients at high risk for developing breast cancer from Brazil. A total of 1267 patients were referred for BRCA genetic testing, and no obligation of fulfilling criteria of mutation probability methods for molecular screening was applied. Germline deleterious mutations in BRCA1/2 (i.e., pathogenic/likely pathogenic variants) were identified in 156 out of 1267 patients (12%). We confirm recurrent mutations in BRCA1/2, but we also report three novel mutations in BRCA2, not previously reported in any public databases or other studies. Variants of unknown significance (VUS) represent only 2% in this dataset and most of them were detected in BRCA2. The overall mutation prevalence in BRCA1/2 was higher in patients diagnosed with cancer at age > 35 years old, and with family history of cancer. The present data expand our knowledge of BRCA1/2 germline mutational spectrum, and it is a valuable clinical resource for genetic counseling and cancer management programs in the country.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 32 条
[1]   Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil [J].
Achatz, Maria Isabel ;
Caleffi, Maira ;
Guindalini, Rodrigo ;
Marques, Renato Moretti ;
Nogueira-Rodrigues, Angelica ;
Ashton-Prolla, Patricia .
JCO GLOBAL ONCOLOGY, 2020, 6 :439-452
[2]   Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation [J].
Anderson, K ;
Jacobson, JS ;
Heitjan, DF ;
Zivin, JG ;
Hershman, D ;
Neugut, AI ;
Grann, VR .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (06) :397-406
[3]   Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? [J].
Beitsch, Peter D. ;
Whitworth, Pat W. ;
Hughes, Kevin ;
Patel, Rakesh ;
Rosen, Barry ;
Compagnoni, Gia ;
Baron, Paul ;
Simmons, Rache ;
Smith, Linda Ann ;
Grady, Ian ;
Kinney, Michael ;
Coomer, Cynara ;
Barbosa, Karen ;
Holmes, Dennis R. ;
Brown, Eric ;
Gold, Linsey ;
Clark, Patricia ;
Riley, Lee ;
Lyons, Samuel ;
Ruiz, Antonio ;
Kahn, Sadia ;
MacDonald, Heather ;
Curcio, Lisa ;
Hardwick, Mary Kay ;
Yang, Shan ;
Esplin, Ed D. ;
Nussbaum, Robert L. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (06) :453-+
[4]   Risk of Late-Onset Breast Cancer in Genetically Predisposed Women [J].
Boddicker, Nicholas J. ;
Hu, Chunling ;
Weitzel, Jeffrey N. ;
Kraft, Peter ;
Nathanson, Katherine L. ;
Goldgar, David E. ;
Na, Jie ;
Huang, Hongyan ;
Gnanaolivu, Rohan D. ;
Larson, Nicole ;
Yussuf, Amal ;
Yao, Song ;
Vachon, Celine M. ;
Trentham-Dietz, Amy ;
Teras, Lauren ;
Taylor, Jack A. ;
Scott, Christopher E. ;
Sandler, Dale P. ;
Pesaran, Tina ;
Patel, Alpa, V ;
Palmer, Julie R. ;
Ong, Irene M. ;
Olson, Janet E. ;
O'Brien, Katie ;
Neuhausen, Susan ;
Martinez, Elena ;
Ma, Huiyan ;
Lindstrom, Sara ;
Le Marchand, Loic ;
Kooperberg, Charles ;
Karam, Rachid ;
Hunter, David J. ;
Hodge, James M. ;
Haiman, Christopher ;
Gaudet, Mia M. ;
Gao, Chi ;
LaDuca, Holly ;
Lacey, James, V ;
Dolinsky, Jill S. ;
Chao, Elizabeth ;
Carter, Brian D. ;
Burnside, Elizabeth S. ;
Bertrand, Kimberly A. ;
Bernstein, Leslie ;
Auer, Paul W. ;
Ambrosone, Christine ;
Yadav, Siddhartha ;
Hart, Steven N. ;
Polley, Eric C. ;
Domchek, Susan M. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (31) :3430-+
[5]   Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site [J].
Brewster, Brooke L. ;
Rossiello, Francesca ;
French, Juliet D. ;
Edwards, Stacey L. ;
Wong, Ming ;
Wronski, Ania ;
Whiley, Phillip ;
Waddell, Nic ;
Chen, Xiaowei ;
Bove, Betsy ;
Hopper, John L. ;
John, Esther M. ;
Andrulis, Irene ;
Daly, Mary ;
Volorio, Sara ;
Bernard, Loris ;
Peissel, Bernard ;
Manoukian, Siranoush ;
Barile, Monica ;
Pizzamiglio, Sara ;
Verderio, Paolo ;
Spurdle, Amanda B. ;
Radice, Paolo ;
Godwin, Andrew K. ;
Southey, Melissa C. ;
Brown, Melissa A. ;
Peterlongo, Paolo .
HUMAN MUTATION, 2012, 33 (12) :1665-1675
[6]   Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021 [J].
Daly, Mary B. ;
Pal, Tuya ;
Berry, Michael P. ;
Buys, Saundra S. ;
Dickson, Patricia ;
Domchek, Susan M. ;
Elkhanany, Ahmed ;
Friedman, Susan ;
Goggins, Michael ;
Hutton, Mollie L. ;
Karlan, Beth Y. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison W. ;
Laronga, Christine ;
Litton, Jennifer K. ;
Mak, Julie S. ;
Menendez, Carolyn S. ;
Merajver, Sofia D. ;
Norquist, Barbara S. ;
Offit, Kenneth ;
Pederson, Holly J. ;
Reiser, Gwen ;
Senter-Jamieson, Leigha ;
Shannon, Kristen Mahoney ;
Shatsky, Rebecca ;
Visvanathan, Kala ;
Weitzel, Jeffrey N. ;
Wick, Myra J. ;
Wisinski, Kari B. ;
Yurgelun, Matthew B. ;
Darlow, Susan D. ;
Dwyer, Mary A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01) :77-102
[7]   Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition [J].
dos Santos, Elizabeth Santana ;
Lallemand, Francois ;
Burke, Leslie ;
Stoppa-Lyonnet, Dominique ;
Brown, Melissa ;
Caputo, Sandrine M. ;
Rouleau, Etienne .
CANCERS, 2018, 10 (11)
[8]   Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations [J].
Fackenthal, James D. ;
Olopade, Olufunmilayo I. .
NATURE REVIEWS CANCER, 2007, 7 (12) :937-948
[9]   Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry [J].
Fernandes, Gabriela C. ;
Michelli, Rodrigo A. D. ;
Galvao, Henrique C. R. ;
Paula, Andre E. ;
Pereira, Rui ;
Andrade, Carlos E. ;
Felicio, Paula S. ;
Souza, Cristiano P. ;
Mendes, Deise R. P. ;
Volc, Sahlua ;
Berardinelli, Gustavo N. ;
Grasel, Rebeca S. ;
Sabato, Cristina S. ;
Viana, Danilo V. ;
Mauad, Edmundo C. ;
Scapulatempo-Neto, Cristovam ;
Arun, Banu ;
Reis, Rui M. ;
Palmero, Edenir I. .
ONCOTARGET, 2016, 7 (49) :80465-80481
[10]   BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian Cancer [J].
Hall, Michael J. ;
Reid, Julia E. ;
Burbidge, Lynn A. ;
Pruss, Dmitry ;
Deffenbaugh, Amie M. ;
Frye, Cynthia ;
Wenstrup, Richard J. ;
Ward, Brian E. ;
Scholl, Thomas A. ;
Noll, Walter W. .
CANCER, 2009, 115 (10) :2222-2233